scholarly article | Q13442814 |
P2093 | author name string | Katsuaki Ieguchi | |
Hiroaki Honda | |||
Masayuki Yamada | |||
Yoshiro Maru | |||
Fujiko Tsukahara | |||
Morichika Takita | |||
Taishi Mishima | |||
P2860 | cites work | Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection | Q22251080 |
Active caspase-1 is a regulator of unconventional protein secretion | Q24308770 | ||
Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics | Q24564912 | ||
Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells | Q24658240 | ||
Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis | Q28275735 | ||
Development of acute lymphoblastic leukemia and myeloproliferative disorder in transgenic mice expressing p210bcr/abl: a novel transgenic model for human Ph1-positive leukemias | Q28504994 | ||
Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients | Q28552532 | ||
Induction of apoptosis in chronic myelogenous leukemia cells through nuclear entrapment of BCR-ABL tyrosine kinase. | Q31929753 | ||
Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patients. | Q33889439 | ||
Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis | Q34020795 | ||
The molecular biology of chronic myeloid leukemia. | Q34079452 | ||
Increased level of myeloid-derived suppressor cells, programmed death receptor ligand 1/programmed death receptor 1, and soluble CD25 in Sokal high risk chronic myeloid leukemia | Q34576982 | ||
Imatinib plus Granulocyte Colony-Stimulating Factor in Chronic Myeloid Leukemia Patients Who Have Achieved Partial or Complete Cytogenetic Response while on Imatinib | Q34832286 | ||
S100A8 and S100A9 induce cytokine expression and regulate the NLRP3 inflammasome via ROS-dependent activation of NF-κB(1.). | Q34973392 | ||
Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia | Q35903505 | ||
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia | Q36047171 | ||
Myeloid derived suppressor cells in human diseases | Q36338349 | ||
Cell death by necrosis: towards a molecular definition | Q36671559 | ||
Regulated expression of P210 Bcr-Abl during embryonic stem cell differentiation stimulates multipotential progenitor expansion and myeloid cell fate | Q37115618 | ||
Autocrine TNF-α production supports CML stem and progenitor cell survival and enhances their proliferation | Q37635609 | ||
Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance | Q37723478 | ||
Pyroptotic death storms and cytopenia | Q38189932 | ||
BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2. | Q38293633 | ||
The tyrosine kinase inhibitors imatinib and dasatinib reduce myeloid suppressor cells and release effector lymphocyte responses | Q38415063 | ||
Bag1 directly routes immature BCR-ABL for proteasomal degradation | Q39673043 | ||
Single-cell imaging of caspase-1 dynamics reveals an all-or-none inflammasome signaling response. | Q40215236 | ||
Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation | Q40305409 | ||
Bcr-Abl expression levels determine the rate of development of resistance to imatinib mesylate in chronic myeloid leukemia | Q40365763 | ||
The murine myeloid cell line 32Dcl3 as a model system for studying neutrophil functions | Q40609967 | ||
The effects of Bcr-Abl on C/EBP transcription-factor regulation and neutrophilic differentiation are reversed by the Abl kinase inhibitor imatinib mesylate | Q40695042 | ||
Bcr/Abl activates transcription of the Bcl-X gene through STAT5. | Q40856047 | ||
Modulation of human G-CSF receptor mRNA and protein in normal and leukemic myeloid cells by G-CSF and retinoic acid | Q41342632 | ||
Granulocyte colony-stimulating factor receptor mRNA upregulation is an immediate early marker of myeloid differentiation and exhibits dysfunctional regulation in leukemic cells. | Q41497116 | ||
Spatio-temporal activation of caspase revealed by indicator that is insensitive to environmental effects | Q42916419 | ||
BCR-ABL promotes neutrophil differentiation in the chronic phase of chronic myeloid leukemia by downregulating c-Jun expression | Q46055740 | ||
Emerging inflammasome effector mechanisms | Q49071287 | ||
Differentiation of PC12 phaeochromocytoma cells induced by v-src oncogene | Q59073572 | ||
Initiation of deregulated growth of multipotent progenitor cells by bcr-abl in vitro | Q67536173 | ||
Hematopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma tumors | Q70019545 | ||
Identification of p8,14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells | Q70141673 | ||
CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs | Q74296227 | ||
G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia | Q79803082 | ||
BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells | Q81656247 | ||
Molecular biology of chronic myeloid leukemia | Q84220622 | ||
P433 | issue | 60 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | imatinib | Q177094 |
cell death | Q2383867 | ||
P304 | page(s) | 31682-31696 | |
P577 | publication date | 2018-08-03 | |
P1433 | published in | Oncotarget | Q1573155 |
P1476 | title | Paradoxical counteraction by imatinib against cell death in myeloid progenitor 32D cells expressing p210BCR-ABL | |
P478 | volume | 9 |
Q91614292 | Infliximab therapy together with tyrosine kinase inhibition targets leukemic stem cells in chronic myeloid leukemia | cites work | P2860 |